Lincosamidas

McGehee, 1968, Comparative studies of antibacterial activity in vitro and absorption and excretion of lincomycin and clindamycin, Am J Med Sci, 256, 279, 10.1097/00000441-196811000-00002 www.who.int/medicines/publications/essentialmedicines/en/index.html. LeCorn, 2007, In vitro activity of amoxicillin, clindamycin, doxycycline, metronidazole, and moxifloxacin against oral actinomyces, J Endod, 33, 557, 10.1016/j.joen.2007.02.002 Rice, 1995, Susceptibilities of Chlamydia trachomatis isolates causing uncomplicated female genital tract infections and pelvic inflammatory disease, Antimicrob Agents Chemother, 39, 760, 10.1128/AAC.39.3.760 Fichera, 1995, In vitro assays elucidate peculiar kinetics of clindamycin action against Toxoplasma gondii, Antimicrob Agents Chemother, 39, 1530, 10.1128/AAC.39.7.1530 Roberts, 1999, Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants, Antimicrob Agents Chemother, 43, 2823, 10.1128/AAC.43.12.2823 Merino Diaz, 2008, Prevalence and mechanisms of erythromycin and clindamycin resistance in clinical isolates of b-haemolytic streptococci of Lancefield groups A, B, C and G in Seville, Spain, Clin Microbiol Infect, 14, 85, 10.1111/j.1469-0691.2007.01881.x Daurel, 2008, Differences in potential for selection of clindamycin-resistant mutants between inducible erm(A) and erm(C) Staphylococcus aureus. Genes, J Clin Microbiol, 46, 546, 10.1128/JCM.01925-07 Cavallo, 2007, Portage nasal de Staphylococcus aureus chez des jeunes incorporés de la marine nationale, Bull Epidemiol Hebd Bernard, 2008, Sensibilité aux antibiotiques des souches de Staphylococcus aureus responsables d’infections cutanées communautaires, Ann Dermatol Venereol, 135, 13, 10.1016/j.annder.2007.06.004 Bouvet, 2004, Émergence de la résistance aux macrolides des Streptococcus pyogenes ou streptocoques bêta-hémolytiques du groupe A, Bull Epidemiol Hebd, 154 Guillemot, 2007, Sensibilité aux macrolides et apparentés de Streptococcus pyogenes (SGA) au cours des angines aiguës en France, hiver 2005-2006, Bull Epidemiol Hebd, 291 Brazier, 2008, European surveillance study on antimicrobial susceptibility of Gram-positive anaerobic cocci, Int J Antimicrob Agents, 31, 316, 10.1016/j.ijantimicag.2007.11.006 Aldridge, 2002, Susceptibility trending of blood isolates of the Bacteroides fragilis group over a 12-year period to clindamycin, ampicillin–sulbactam, cefoxitin, imipenem, and metronidazole, Anaerobe, 8, 301, 10.1016/S1075-9964(03)00028-3 Snydman, 2007, National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004, Antimicrob Agents Chemother, 51, 1649, 10.1128/AAC.01435-06 Nicholas, 1975, Concentration of clindamycin in human bone, Antimicrob Agents Chemother, 8, 220, 10.1128/AAC.8.2.220 Panzer, 1972, Clindamycin levels in various body tissues and fluids, J Clin Pharmacol New Drugs, 12, 259, 10.1002/j.1552-4604.1972.tb00052.x Joiner, 1981, Antibiotic levels in infected and sterile subcutaneous abscesses in mice, J Infect Dis, 143, 487, 10.1093/infdis/143.3.487 Prokesch, 1982, Antibiotic entry into human polymorphonuclear leucocytes, Antimicrob Agents Chemother, 23, 373, 10.1128/AAC.21.3.373 www.vidal.fr/substances/6742/clindamycine. Liu, 2011, Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children, Clin Infect Dis, 52, 1, 10.1093/cid/cir034 Stevens, 2014, Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America, Clin Infect Dis, 59, e10, 10.1093/cid/ciu296 Lipsky, 2012, 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections, Clin Infect Dis, 54, 132, 10.1093/cid/cis346 Berbari, 2015, 2015 Infectious Diseases Society of America (IDSA) clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults, Clin Infect Dis, 61, e26, 10.1093/cid/civ482 www.aidsinfo.nih.gov/guidelines.